Latest News and Press Releases

--Stage 1 of Clinical Trial Completed; A Tamsulosin DRS Formulation is Selected That Demonstrates Profile Similar to FLOMAX® and May Provide Other Potential Advantages, Including Ease-of-Use and...

MIAMI, April 11, 2017 (GLOBE NEWSWIRE) -- The Female Health Company / Veru Healthcare (NASDAQ:FHCO) today announced the appointment of Robert H. Getzenberg, Ph.D., as Executive Vice President of...

MIAMI, March 09, 2017 (GLOBE NEWSWIRE) -- The Female Health Company / Veru Healthcare (NASDAQ:FHCO) today announced that it has initiated Stage 1 of a bioequivalence (BE) clinical trial designed to...

MIAMI, March 03, 2017 (GLOBE NEWSWIRE) -- The Female Health Company / Veru Healthcare (NASDAQ:FHCO) today announced that it will host a conference call to update investors on the Company’s product...

MIAMI, Feb. 16, 2017 (GLOBE NEWSWIRE) -- The Female Health Company / Veru Healthcare (NASDAQ:FHCO) today announced the appointment of Matthew C. Gosnell, Ph.D., as Senior Vice President of...

MIAMI, Feb. 09, 2017 (GLOBE NEWSWIRE) -- The Female Health Company / Veru Healthcare (NASDAQ:FHCO) (the Company) today reported its financial results for the fiscal 2017 first quarter ended December...

MIAMI, Jan. 06, 2017 (GLOBE NEWSWIRE) -- The Female Health Company / Veru Healthcare (NASDAQ:FHCO) today announced the U.S. launch of PREBOOST® (topical 4% benzocaine wipes) that helps in the...

MIAMI, Jan. 05, 2017 (GLOBE NEWSWIRE) -- The Female Health Company / Veru Healthcare (NASDAQ:FHCO) today announced the appointment of Brian J. Groch as Chief Commercial Officer, effective January 1,...

MIAMI, Jan. 04, 2017 (GLOBE NEWSWIRE) -- The Female Health Company / Veru Healthcare (NASDAQ:FHCO) today announced that, through its exclusive distributor in Brazil, Semina Indústria e Comércio Ltda...

MIAMI, Dec. 12, 2016 (GLOBE NEWSWIRE) -- The Female Health Company / Veru Healthcare (NASDAQ:FHCO) (FHC or the Company) today reported its financial results for the fiscal 2016 fourth quarter and...